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astric vascular ectasia
n  children: Case reports
ctasia vascular gástrica en nin˜os:
eporte de casos
astric  antral  vascular  ectasia  (GAVE),  called  ‘‘watermelon
tomach’’  is  rare  and  has  been  reported  as  a  cause  of
on-variceal  gastrointestinal  bleeding  in  4%  of  adults.  Only
solated  cases  have  been  reported  in  children,  but  its  oppor-
une  recognition  and  treatment  are  important,  given  that
t  can  manifest  as  an  acute  and  life-threatening  bleeding
pisode.1,2 It  has  been  associated  with  other  pathologies,
uch  as  autoimmune  diseases,  chronic  renal  insufﬁciency,Figure  1  Vascular  ectases,  ‘‘watermelon  stomach’’,  in  the
gastric  corpus.
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Ond  liver  cirrhosis,  as  well  as  with  patients  undergoing  treat-
ent  with  immunosuppressants.1--3 Its  endoscopic  image  is
escribed  as  linear,  erythematous  spots  that  irradiate  from
he  pylorus  to  the  antrum.  Sometimes  it  has  the  appear-
nce  of  erosive  gastritis  and  it  can  also  be  located  in  other
reas,  such  as  the  cardia,  small  bowel,  and  rectum,  hence
ts  suggested  name  of  gastric  vascular  ectasia  (GVE).2,4,5 We
resent  herein  3  pediatric  cases  of  endoscopically  diagnosed
VE  treated  with  argon  plasma  electrocoagulation  (APE).
Case  1:  A  15-month-old  boy  diagnosed  with  Wiskott-
ldrich  syndrome  presented  with  gastroesophageal  reﬂux
isease  that  responded  poorly  to  treatment.  Occult  bleeding
ith  anemia  with  Hb  10.5  g/dl  was  detected.  Gastrointesti-
al  endoscopy  revealed  an  image  consistent  with  GVE  in  the
orpus  and  fundus  and  APE  was  performed.  The  patient  had
symptomatic  progression  with  Hb  of  12.5  g/dl.
Case  2:  A  girl,  aged  4  years  6  months,  presented  with
cute  infectious  diarrhea  prior  to  an  episode  of  melena  and
ad  a  low  Hb  level  of  6.7  g/dl.  Endoscopy  revealed  an  image
f  GVE  in  the  fundus  and  APE  was  performed.  In  the  control
ndoscopy  at  4  weeks,  a  2nd  APE  session  was  performed
n  minimal  vascular  lesions  with  no  further  gastrointestinal
leeding  and  a  control  Hb  of  12.5  g/dl.
Case  3:  A  9-year-old  girl  presented  with  acquired  aplastic
nemia,  hematamesis,  and  a  drop  in  the  Hb  level  to  3  g/dl.
ndoscopy  revealed  ‘‘watermelon  stomach’’  lesions  in  the
orpus  and  fundus  (Fig.  1).  APE  was  applied  and  the  patient
rogressed  with  no  further  bleeding.  The  control  endoscopy
t  4  weeks  showed  no  change  in  the  vascular  lesions  and
 second  APE  session  was  applied.  Two  months  later,  the
atient  presented  with  a  new  episode  of  hematemesis  due
o  GVE  in  the  fundus  and  corpus.  A  third  APE  session  was
pplied,  controlling  the  acute  gastrointestinal  bleeding.  One
onth  later,  the  patient  died  due  to  intracranial  hemor-
hage.
The  histopathology  report  in  cases  1  and  2  stated  follic-
lar  gastritis  of  the  gastric  fundus.
GVE  can  present  as  upper  gastrointestinal  bleeding,
ccult  bleeding  with  anemia,  or  as  abdominal  pain.  In  our
ases,  gastrointestinal  bleeding  and  anemia  were  the  man-
festations  of  GVE  that  were  corrected  following  treatment
 Please cite this article as: Membren˜o-Ortíz G, Miranda-
arbachano K, Flores-Calderón J, González-Ortíz B, Siordia-Reyes
. Ectasia vascular gástrica en nin˜os: reporte de casos. Revista de
astroenterología de México. 2016;81:232--233.
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iigure  2  Application  of  argon  plasma  electrocoagulation  in
ascular  ectases  in  the  gastric  fundus  (arrow).
ith  APE  (Fig.  2) in  cases  1  and  2.  In  case  3,  both  episodes
f  active  bleeding  were  able  to  be  contained  through  APE.
e  found  an  association  with  autoimmune  diseases  and  with
mmunosuppressant  treatment,  concurring  with  reports  in
he  literature.1,4,6 Treatment  in  adults  for  GAVE  consists
f  endoscopic  management  with  APE,  laser  photoablation,
itrous  oxide  cryotherapy,  and  coagulation  with  hemospray.
PE  is  the  most  widely  used  technique  due  to  its  avail-
bility  and  its  generally  reversible  complications,  such  as
istension  due  to  gas,  emphysema,  and  gastrointestinal
neumatosis,  unlike  the  complications  of  perforation  or
lcers  that  can  arise  with  other  endoscopic  techniques.2,5
ther  reported  treatments  are  antrectomy,  which  involves
reater  morbidity  and  mortality,  and  medical  treatments
ith  hormones,  steroids,  or  tranexamic  acid.  The  latter
ave  not  been  efﬁcacious,  given  that  they  require  long-
erm  management  and  cause  adverse  effects  and  relapse
hen  suspended.  Some  reports  state  that  acute  bleed-
ng  has  been  controlled  with  octreotide.2,5,6 There  is  little
nformation  on  the  use  of  APE  in  children  for  managing
SCIENTIFIC  LETTERS  
bleeding  caused  by  GAVE.  Our  cases  did  not  present  with
complications.
We  can  conclude  that  APE  in  children  with  GAVE,  as  in
adults,  is  useful  for  controlling  active  bleeding,  without
causing  serious  complications.  The  pathology  should  be  sus-
pected  in  children  presenting  with  gastrointestinal  bleeding
that  causes  anemia,  who  are  undergoing  treatment  with
immunosuppressants  and/or  have  an  autoimmune  disease.
Biopsy  may  not  always  report  vascular  lesions.  An  endo-
scopic  image  characteristic  of  GVE  with  no  other  etiology
for  gastrointestinal  bleeding  that  responds  favorably  to  APE
treatment  supports  the  diagnosis.  GAVE  should  be  consid-
ered  a  cause  of  gastrointestinal  bleeding  in  the  pediatric
population.
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Endoscopic treatment of
recurrent tracheoesophageal
ﬁstula with a combination
of  N-butyl-2-cyanocrylate
(Histoacryl®) and lipiodol via
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patient
Tratamiento endoscópico de fístula
traqueoesofágica recurrente con una
combinación de N-butyl-2-cianocrilato
(Histoacryl®) y lipiodol por esofagoscopia
en pediatría
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sophagogastroduodenoscopy  (EGD)  are  the  diagnostic
ethods  of  choice,  but  repeat  studies  may  be  required
or  conﬁrmation.5 Endoscopic  treatment  of  recurrent  TEF
as  been  described  as  a  therapeutic  alternative  to  repeat
pen  chest  surgery  repair.  Some  studies  have  reported  on
he  use  of  tissue  adhesives  such  as  N-butyl-cyanoacrylate
Histoacryl®),  ﬁbrin  or  sclerosing  agents,  and  laser.1--3 We
escribe  herein  the  case  of  a  preschool  child  with  recurrent
EF  managed  with  a  combination  of  Histoacryl® and  lipiodol
ia  esophageal  endoscopy.5
A  3-year-old  girl  was  delivered  by  cesarean  section  at
4  weeks  of  gestation,  G2,  weighing  1.5  kg,  and  measuring
0  cm.  She  had  a past  history  of  severe  oligohydramnios,
ntrauterine  growth  retardation,  and  umbilical  catheter-
zation.  She  underwent  esophagoplasty  at  5  days  of  life
ith  ﬁstula  closure  due  to  type  III  EA  and  TEF  at  another
nstitution.  At  19  months  of  age  the  patient  was  referred  to
he  Gastroenterology  and  Nutrition  Service  of  our  hospital
ecause  of  upper  gastrointestinal  bleeding  causing  anemia.
he  was  diagnosed  with  grade  III  esophageal  varices  sec-
ndary  to  portal  hypertension  and  cavernous  transformation
f  the  portal  vein  and  was  managed  with  endoscopic  variceal
and  ligation  and  sclerotherapy  with  no  complications.
tarting  at  24  months  of  life,  the  patient  presented  with
ymptoms  of  repeat  pneumonia,  gastroesophageal  reﬂux,
ronchial  hyperreactivity,  esophageal  candidiasis,  pediatric
hronic  lung  disease,  and  chronic  malnutrition,  meriting
umerous  hospitalizations  and  the  use  of  proton  pump
nhibitors,  inhaled  steroids,  and  short-acting  bronchodila-
ors.  An  EGD  was  performed  when  the  patient  was  3
ears  old,  identifying  the  TEF  opening  at  16  cm  from  the
